» Articles » PMID: 35645986

Red Blood Cell Distribution Width to Platelet Count Ratio Facilitates Preoperative Prediction of Recurrence in Surgically Treated Chronic Subdural Hematoma

Overview
Journal Front Neurol
Specialty Neurology
Date 2022 Jun 1
PMID 35645986
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Recent studies have demonstrated emerging evidence of the role of inflammation in the growth and recurrence of chronic subdural hematoma (cSDH). Red blood cell distribution width to platelet count ratio (RPR) is a novel biomarker for inflammation in cancer, cardiac, and inflammatory diseases. The present retrospective study investigated the impact of RPR on recurrence after burr hole surgery for cSDH in 297 patients.

Methods: The optimal cut-off value for RPR was defined as ≥0.0568 according to the receiver operating characteristic curve (AUC:0.64, 95%CI:0.55-0.72, = 0.007). The study cohort was dichotomized into low ( = 157) and high ( = 140) RPR groups.

Results: Significant differences between the groups were identified regarding American Society of Anesthesiologists (ASA) classification and frequency of anticoagulant intake. Demographics, comorbidities, size, morphology, and mass effect of cSDH were homogeneously distributed among the RPR groups. Multivariable binary logistic regression analysis considering location, midline-shift, septation, RPR, anticoagulant intake, sex, and ASA classification revealed that an increased baseline RPR (≥0.0568, OR: 3.1, 95%CI: 1.4-6.8, = 0.004), and preoperative midline-shift (≥5 mm, OR: 2.7, 95%CI: 1.3-6.0, = 0.01) are independent predictors of recurrent cSDH.

Conclusion: The present findings suggest RPR as a novel inflammatory biomarker enabling risk stratification of recurrence after burr hole surgery for cSDH and might facilitate tailored medical decision making.

Citing Articles

Effect of decreased platelets on postoperative recurrence of chronic subdural hematoma.

Yagi K, Matsubara M, Kanda E, Minami Y, Hishikawa T Front Neurol. 2024; 14:1308991.

PMID: 38178882 PMC: 10765528. DOI: 10.3389/fneur.2023.1308991.


Biofluid Biomarkers in the Prognosis of Chronic Subdural Hematoma: A Systematic Scoping Review.

Georgountzos G, Gkalonakis I, Anastasopoulos L, Stranjalis G, Kalamatianos T Diagnostics (Basel). 2023; 13(14).

PMID: 37510193 PMC: 10378324. DOI: 10.3390/diagnostics13142449.


Anti-Inflammatory Drug Therapy in Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis of Prospective Randomized, Double-Blind and Placebo-Controlled Trials.

Vychopen M, Guresir E, Wach J Int J Mol Sci. 2022; 23(24).

PMID: 36555838 PMC: 9784956. DOI: 10.3390/ijms232416198.

References
1.
Muller W, Firsching R . Significance of eosinophilic granulocytes in chronic subdural hematomas. Neurosurg Rev. 1990; 13(4):305-8. DOI: 10.1007/BF00346370. View

2.
Xanthopoulos A, Giamouzis G, Melidonis A, Kitai T, Paraskevopoulou E, Paraskevopoulou P . Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus. Cardiovasc Diabetol. 2017; 16(1):81. PMC: 5501451. DOI: 10.1186/s12933-017-0563-1. View

3.
Lorente L, Martin M, Ruiz C, Abreu-Gonzalez P, Perez-Cejas A, Gonzalez-Rivero A . Red blood cell distribution width as mortality biomarker in patients with traumatic brain injury. Acta Neurol Belg. 2020; 121(3):715-720. DOI: 10.1007/s13760-020-01409-z. View

4.
Stanisic M, Lyngstadaas S, Pripp A, Aasen A, Lindegaard K, Ivanovic J . Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta Neurochir (Wien). 2011; 154(1):113-20. DOI: 10.1007/s00701-011-1203-2. View

5.
Narum S, Westergren T, Klemp M . Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014; 4(5):e004587. PMC: 4025450. DOI: 10.1136/bmjopen-2013-004587. View